Blood-based biomarkers may help identify fibrotic interstitial lung diseases, offering a less invasive adjunct to imaging and pulmonary function testing, according to a systematic review and meta-analysis.
Blood-based biomarkers may help identify fibrotic interstitial lung diseases, offering a less invasive adjunct to imaging and pulmonary function testing, according to a systematic review and meta-analysis.
Blood-based biomarkers may help...